2026年11月4日星期三
M
Pandaigdigang Talaan
Pandaigdigang Flash News
Apple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaSingapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei AsiaThe great yen rebalancing— 日经 Nikkei AsiaNintendo's Mario creator Miyamoto sees 'things we can do' even in AI era— 日经 Nikkei AsiaNorth Korea leans on China and Russia to drive 3% economic growth— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaSingapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei AsiaThe great yen rebalancing— 日经 Nikkei AsiaNintendo's Mario creator Miyamoto sees 'things we can do' even in AI era— 日经 Nikkei AsiaNorth Korea leans on China and Russia to drive 3% economic growth— 日经 Nikkei Asia

Calpain-5 mediates STIP1 degradation via triggering N-degron pathway to suppress epithelial ovarian cancer progression and CAPN5low-STIP1high status indicates Pimitespib susceptibility

Pinagmulan Nature 生命科学8 araw ang nakalipas
Buod ng nilalaman

Ang site na ito ay nagbibigay lamang ng index ng pamagat at buod; ang buong nilalaman at copyright ay pag-aari ng orihinal na tagapaglathala. Mangyaring i-click ang orihinal na link upang basahin.

Pumunta sa orihinal na teksto
Kabilang channel
Agham
Kabilang rehiyon
Pandaigdigang pananaw
Wika ng orihinal
English
Numero ng entry
science-109089d0

Comments 0 comments

No comments yet. Be the first.

Calpain-5 mediates STIP1 degradation via triggering N-degron pathway to suppress epithelial ovarian cancer progression and CAPN5low-STIP1high status indicates Pimitespib susceptibility · Pandaigdigang Talaan